Clopidogrel and Sputum discolored - a phase IV clinical study of FDA data

Summary:

Sputum discolored is reported as a side effect among people who take Clopidogrel (clopidogrel), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Singulair, and have Asthma.

The phase IV clinical study analyzes which people have Sputum discolored when taking Clopidogrel. It is created by eHealthMe based on reports of 91,038 people who have side effects when taking Clopidogrel from the FDA, and is updated regularly.

What is Clopidogrel?

Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.

What is Sputum discolored?

Sputum discolored is found to be associated with 915 drugs and 552 conditions by eHealthMe. Check the latest studies of Sputum discolored.

On Jul, 05, 2026

91,038 people reported to have side effects when taking Clopidogrel.
Among them, 94 people (0.1%) have Sputum discolored.

Could Clopidogrel cause Sputum discolored?

Among these 94 people:

How long have people been on Clopidogrel when they have Sputum discolored? *

What is the gender of people who have Sputum discolored when taking Clopidogrel? *

female: 61.84 %
male: 38.16 %

What is the age of people who have Sputum discolored when taking Clopidogrel? *

What are other drugs people take besides Clopidogrel? *

What are other side effects people have besides Sputum discolored? *

Dyspnea (difficult or laboured breathing): 60 people, 63.83%
Fatigue (feeling of tiredness): 51 people, 54.26%
Cough: 47 people, 50.00%
Productive Cough: 43 people, 45.74%
Dizziness: 42 people, 44.68%
Joint Pain: 36 people, 38.30%
Wheezing (a high-pitched whistling sound made while you breath): 36 people, 38.30%
Nasopharyngitis (inflammation of the nasopharynx): 35 people, 37.23%
Muscle Aches (muscle pain): 32 people, 34.04%
Back Pain: 32 people, 34.04%

What are the existing conditions these people have? *

Asthma: 28 people, 29.79%
High Blood Pressure: 19 people, 20.21%
Muscle Spasms (muscle contraction): 18 people, 19.15%
Dyspnea (difficult or laboured breathing): 17 people, 18.09%
Inflammation: 16 people, 17.02%
Cough: 14 people, 14.89%
Primary Myelofibrosis (primary disorder of the bone marrow): 12 people, 12.77%
Gout (uric acid crystals building up in the body): 5 people, 5.32%
Psoriasis (immune-mediated disease that affects the skin): 5 people, 5.32%
Parkinson's Disease: 4 people, 4.26%

* Approximation only. Some reports may have incomplete information.

Do you take Clopidogrel and have Sputum discolored?

- Check whether Sputum discolored is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clopidogrel:

Clopidogrel (92,160 reports)

Browse all side effects of Clopidogrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sputum discolored:

Sputum discolored (915 drugs)

Browse all the conditions that are associated with Sputum discolored:

Sputum discolored (552 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on clopidogrel (the active ingredients of Clopidogrel) and Clopidogrel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.